Susan D. Wyrick serves as Executive at ONCOGENEX PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Susan D. Wyrick has executed 13 insider transactions totaling $5.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2025 involved selling 873 shares valued at $4.6K.
Susan D. Wyrick currently holds 180,790 shares of ONCOGENEX PHARMACEUTICALS, INC. (OGXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan D. Wyrick has been a net seller of OGXI stock. They have purchased $0 and sold $5.6K worth of shares.
Susan D. Wyrick's most recent insider trade was on Dec 15, 2025, when they sold 873 shares at $5.22 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 4, 2025 | SANA | $11.4K | Payment | 2,565 | $4.44 | Discretionary |
| Dec 3, 2025 | SANA | $0 | Option Exercise | 10,000 | $N/A | Discretionary |
| Jun 4, 2025 | SANA | $6.0K | Payment | 2,567 | $2.32 | Discretionary |
| Jun 3, 2025 | SANA | $0 | Option Exercise | 10,000 | $N/A | Discretionary |
| Mar 17, 2014 | OGXI | $2.2K | Sale | 182 | $12.25 | Discretionary |
| Mar 14, 2014 | OGXI | $0 | Option Exercise | 516 | $N/A | Discretionary |
| Oct 2, 2013 | OGXI | $1.7K | Sale | 191 | $9.04 | Discretionary |
| Oct 1, 2013 | OGXI | $0 | Option Exercise | 688 | $N/A | Discretionary |
| Aug 19, 2013 | OGXI | $1.7K | Sale | 194 | $8.68 | Discretionary |
| Aug 13, 2013 | OGXI | $0 | Option Exercise | 1,363 | $N/A | Discretionary |
| Aug 13, 2013 | OGXI | $0 | Payment | 372 | $N/A | Discretionary |